Purification of biologically active apolipoproteins by chromatofocussing

Roger McLeod, Andras G. Lacko, P. Haydn Pritchard, Jiri Frohlich

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Chromatofocussing has been used to isolate homogeneous apolipoproteins (apo) from human very-low-density lipoproteins and high-density lipoproteins with protein recovery of 70%. The inclusion of sulfhydryl-reducing agent (dithiothreitol) was required during solubilization of the lipoproteins (following delipidation) to achieve reproducible elution profiles. Removal of polyvalent buffers from apoproteins was rapidly accomplished on small columns of hydroxylapatite. The biological activity of purified apo AI and apo CII was confirmed by assessment of their ability to activate lecithin:cholesterol acyltransferase or lipoprotein lipase, respectively. Functional properties of isolated apo E were assessed by in vitro interaction with the low-density lipoprotein receptor expressed by cultured fibroblasts. Apolipoproteins purified by this rapid procedure exhibit identical physical, chemical and biological properties to those purified by other, more tedious techniques.

Original languageEnglish
Pages (from-to)271-283
Number of pages13
JournalJournal of Chromatography B: Biomedical Sciences and Applications
Volume381
Issue numberC
DOIs
StatePublished - 1 Jan 1986

Fingerprint

Apolipoproteins
Purification
Apolipoprotein C-II
Phosphatidylcholine-Sterol O-Acyltransferase
Apoproteins
VLDL Lipoproteins
Lipoprotein Lipase
LDL Receptors
Dithiothreitol
Apolipoprotein A-I
Reducing Agents
Apolipoproteins E
HDL Lipoproteins
Durapatite
Fibroblasts
Bioactivity
Lipoproteins
Buffers
Recovery
Proteins

Cite this

@article{d022c86c951640e0bff5887d40841ae6,
title = "Purification of biologically active apolipoproteins by chromatofocussing",
abstract = "Chromatofocussing has been used to isolate homogeneous apolipoproteins (apo) from human very-low-density lipoproteins and high-density lipoproteins with protein recovery of 70{\%}. The inclusion of sulfhydryl-reducing agent (dithiothreitol) was required during solubilization of the lipoproteins (following delipidation) to achieve reproducible elution profiles. Removal of polyvalent buffers from apoproteins was rapidly accomplished on small columns of hydroxylapatite. The biological activity of purified apo AI and apo CII was confirmed by assessment of their ability to activate lecithin:cholesterol acyltransferase or lipoprotein lipase, respectively. Functional properties of isolated apo E were assessed by in vitro interaction with the low-density lipoprotein receptor expressed by cultured fibroblasts. Apolipoproteins purified by this rapid procedure exhibit identical physical, chemical and biological properties to those purified by other, more tedious techniques.",
author = "Roger McLeod and Lacko, {Andras G.} and Pritchard, {P. Haydn} and Jiri Frohlich",
year = "1986",
month = "1",
day = "1",
doi = "10.1016/S0378-4347(00)83593-8",
language = "English",
volume = "381",
pages = "271--283",
journal = "Journal of Chromatography B: Biomedical Sciences and Applications",
issn = "0378-4347",
number = "C",

}

Purification of biologically active apolipoproteins by chromatofocussing. / McLeod, Roger; Lacko, Andras G.; Pritchard, P. Haydn; Frohlich, Jiri.

In: Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 381, No. C, 01.01.1986, p. 271-283.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Purification of biologically active apolipoproteins by chromatofocussing

AU - McLeod, Roger

AU - Lacko, Andras G.

AU - Pritchard, P. Haydn

AU - Frohlich, Jiri

PY - 1986/1/1

Y1 - 1986/1/1

N2 - Chromatofocussing has been used to isolate homogeneous apolipoproteins (apo) from human very-low-density lipoproteins and high-density lipoproteins with protein recovery of 70%. The inclusion of sulfhydryl-reducing agent (dithiothreitol) was required during solubilization of the lipoproteins (following delipidation) to achieve reproducible elution profiles. Removal of polyvalent buffers from apoproteins was rapidly accomplished on small columns of hydroxylapatite. The biological activity of purified apo AI and apo CII was confirmed by assessment of their ability to activate lecithin:cholesterol acyltransferase or lipoprotein lipase, respectively. Functional properties of isolated apo E were assessed by in vitro interaction with the low-density lipoprotein receptor expressed by cultured fibroblasts. Apolipoproteins purified by this rapid procedure exhibit identical physical, chemical and biological properties to those purified by other, more tedious techniques.

AB - Chromatofocussing has been used to isolate homogeneous apolipoproteins (apo) from human very-low-density lipoproteins and high-density lipoproteins with protein recovery of 70%. The inclusion of sulfhydryl-reducing agent (dithiothreitol) was required during solubilization of the lipoproteins (following delipidation) to achieve reproducible elution profiles. Removal of polyvalent buffers from apoproteins was rapidly accomplished on small columns of hydroxylapatite. The biological activity of purified apo AI and apo CII was confirmed by assessment of their ability to activate lecithin:cholesterol acyltransferase or lipoprotein lipase, respectively. Functional properties of isolated apo E were assessed by in vitro interaction with the low-density lipoprotein receptor expressed by cultured fibroblasts. Apolipoproteins purified by this rapid procedure exhibit identical physical, chemical and biological properties to those purified by other, more tedious techniques.

UR - http://www.scopus.com/inward/record.url?scp=0022531537&partnerID=8YFLogxK

U2 - 10.1016/S0378-4347(00)83593-8

DO - 10.1016/S0378-4347(00)83593-8

M3 - Article

C2 - 3760085

AN - SCOPUS:0022531537

VL - 381

SP - 271

EP - 283

JO - Journal of Chromatography B: Biomedical Sciences and Applications

JF - Journal of Chromatography B: Biomedical Sciences and Applications

SN - 0378-4347

IS - C

ER -